Skip to content
Governance Register

← US public companies

Mauro David J

SEC-identified person · CIK 1621172 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Recursion Pharmaceuticals, INC. RXRX Chief Medical Officer filed 2023 - 2024
Codiak Biosciences, Inc. CDAK Chief Medical Officer filed 2022 - 2023
Prelude Therapeutics Inc PRLD Chief Medical Officer filed 2020 - 2021
Ayala Pharmaceuticals, Inc. ADXS Chief Medical Officer filed 2014 - 2016

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.